In the same AD transcriptomics dataset, we observed decreased Nr1d1 (REV-ERBα) expression in AD patient samples (Fig. 5a), suggesting that diminished REV-ERBα could contribute to abnormal high expression of PLIN2 (and perhaps increased LDs) in AD brain. This evidence concerns the gene PLIN2 and Alzheimer disease.